60
Immunovant, Inc. raises $450M under Reg D
Company raise · Closed · NEW YORK, NY · Form D filed 2025-01-21
$50M+ raiseFirst raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Christopher Van Tuyl | Executive Officer |
| Michael Geffner | Executive Officer |
| Andrew Fromkin | Director |
| Atul Pande | Director |
| George Migausky | Director |
| Eric Venker | Director |
| Frank Torti | Director |
| Pete Salzmann | Executive Officer, Director |
| Jay Stout | Executive Officer |
| Melanie Gloria | Executive Officer |
| Eva Renee Barnett | Executive Officer |
| Bill Macias | Executive Officer |
| Douglas Hughes | Director |
Signed by Christopher Van Tuyl, Chief Legal Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.